Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging

Targeted protein degradation has emerged as a powerful strategy for addressing disease‑associated proteins that resist traditional inhibition. However, advancing degrader programs requires screening tools capable of distinguishing true target degradation from off‑target effects and cytotoxicity early in discovery. This work highlights how high‑content imaging (HCI) can meet that challenge by delivering rich, multiparametric data from a single cellular assay.

Using an immunofluorescence‑based HCI workflow optimized for throughput and scalability, researchers screened a 100,000‑compound library while simultaneously quantifying target degradation, pathway effects, and cellular health at single‑cell resolution. By integrating automated imaging, multiplexed biomarker analysis, and flexible assay design, the platform enabled rapid hit triage, early IC₅₀ determination, and efficient SAR iteration.

The approach produced high hit‑confirmation rates and candidates that translated successfully into patient‑derived cell models and in vivo studies. This streamlined, data‑dense strategy demonstrates how high‑content imaging bridges chemistry and biology to accelerate protein degrader programs from hit discovery to IND‑enabling stages.